Quarterly report · Q3
6856.TEDINET S100PM9V
Period2022-01-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥185.1bn | 2022-01-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥224.3bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥154.0bn | 2021-01-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥28.6bn | 2022-01-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥19.9bn | 2021-01-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥29.5bn | 2022-01-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥32.0bn | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥19.9bn | 2021-01-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥29.9bn | 2022-01-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥19.8bn | 2021-01-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥20.7bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥21.3bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥13.7bn | 2021-01-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥20.7bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥13.7bn | 2021-01-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥402.3bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥371.6bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥357.8bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥169.1bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥167.1bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥233.2bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥204.5bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥194.4bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥132.2bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥135.0bn | at 2021-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥490.4 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥224.09 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥505.05 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥325.17 | 2021-01-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥117.93 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥487.86 | 2022-01-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥502.46 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥323.51 | 2021-01-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 57.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.8% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.1% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥41.3bn |
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥41.3bn |
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥3.3bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥21.6bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥21.6bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥21m |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥15.4bn |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥15.4bn |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥981m |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥25.4bn |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥25.4bn |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥1.7bn |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥81.4bn |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥81.4bn |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥29.2bn |
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥37.3bn |
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥37.3bn |
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | segment profit | 2021-01-01 → 2021-09-30 | −¥1.9bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥19.1bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥19.1bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥84m |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥14.6bn |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥14.6bn |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥1.3bn |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥20.3bn |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥20.3bn |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥692m |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥62.7bn |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥62.7bn |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥19.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 401
| Item | Context | Value | Unit |
|---|---|---|---|
| Liabilities | CurrentQuarterInstant | 169083000000 | JPY |
| Capital stock | Prior1YearInstant | 12011000000 | JPY |
| Capital stock | CurrentQuarterInstant | 12011000000 | JPY |
| Capital surplus | Prior1YearInstant | 18624000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 18684000000 | JPY |
| Retained earnings | Prior1YearInstant | 166892000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 180630000000 | JPY |
| Treasury stock | Prior1YearInstant | -1323000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -1195000000 | JPY |
| Shareholders equity | Prior1YearInstant | 196204000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 210129000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 5664000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 4094000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 1889000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 18297000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | -69000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | -65000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 7484000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 22326000000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 791000000 | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 771000000 | JPY |
| Non controlling interests | Prior1YearInstant | 12000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 3000000 | JPY |
| Net assets | Prior1YearInstant | 204493000000 | JPY |
| Net assets | CurrentQuarterInstant | 233231000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 371585000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 402314000000 | JPY |
| Net sales | Prior1YTDDuration | 153957000000 | JPY |
| Net sales | CurrentYTDDuration | 185121000000 | JPY |
| Cost of sales | Prior1YTDDuration | 89252000000 | JPY |
| Cost of sales | CurrentYTDDuration | 106113000000 | JPY |
| Gross profit | Prior1YTDDuration | 64704000000 | JPY |
| Gross profit | CurrentYTDDuration | 79007000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 44845000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 50435000000 | JPY |
| Operating income | Prior1YTDDuration | 19859000000 | JPY |
| Operating income | CurrentYTDDuration | 28571000000 | JPY |
| Interest income noi | Prior1YTDDuration | 143000000 | JPY |
| Interest income noi | CurrentYTDDuration | 315000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 119000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 158000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | － | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 568000000 | JPY |
| Subsidy income noi bounty | Prior1YTDDuration | 69000000 | JPY |
| Subsidy income noi bounty | CurrentYTDDuration | 102000000 | JPY |
| Miscellaneous income noi | Prior1YTDDuration | 279000000 | JPY |
| Miscellaneous income noi | CurrentYTDDuration | 330000000 | JPY |
| Non operating income | Prior1YTDDuration | 610000000 | JPY |
| Non operating income | CurrentYTDDuration | 1475000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 364000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |